Embedded Files
Lexi Ventures is a leading investor in gene tech startups.
This focus is rooted in these beliefs.
Genetic engineering is one of humanity's most powerful technologies.
It will enable a generation of world-changing companies.
Few investors realize this yet.
Gene tech startups aim to cure many of the most agonizing and expensive diseases, improving happiness and reducing healthcare needs. Other gene tech startups will enable plants and microbes to produce newer and better things while sustaining the natural environment.
Lexi Ventures has diversification across health, consumer products, food, materials, and other sectors. We invest around seed stage in US companies involved with DNA, RNA, cells, and omics.
For Startups
Lexi Ventures provides seed and pre-seed stage funding for US-based startups applying or enabling gene tech or synthetic biology.
Our key words are DNA, RNA, cell, omics.
Please connect if you are working on any of these.
A novel type of cell or gene therapy
Diagnostics using DNA, RNA, or proteins
Genetically engineered plants or microbes
Related software, chemistry, or devices
Lexi Ventures tends not to invest in
Small molecules
Single therapeutic assets
Medical devices
Consumer-facing software
Jonah Probell
Founder and Managing Partner
Jonah held founder, executive, and engineering roles in 7 startups. He achieved 2 IPOs, 16 granted patents and wrote 2 books. He has a lifelong interest in science, engineering, economics, philosophy, and innovation.
Jonah is known for:
experience in many startups and roles
transparency and honesty
meticulous attention to details and finishing the job
concern with alignment of interests and prioritizing others' success
a patient approach to investing
Report abuse